Balchem Corporation | Mid-cap | Basic Materials
$144.64
3.09%
| Balchem Stock Comparison:
Balchem vs Linde plcBalchem vs Sherwin-WilliamsBalchem vs AlbemarleBalchem vs NewMarketBalchem vs Eastman ChemicalBalchem vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 255.5M
Gross Profit 93.1M 36.45%
Operating Income 51.4M 20.14%
Net Income 38.3M 14.98%

Balance Sheet Metrics

Total Assets 1.6B
Total Liabilities 408.9M
Shareholders Equity 1.2B
Debt to Equity 0.34

Cash Flow Metrics

Operating Cash Flow 38.0M
Free Cash Flow 30.9M

Revenue & Profitability Trend

Balchem Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue i 953.7M 922.4M 942.4M 799.0M 703.6M
Cost of Goods Sold i 617.5M 620.4M 661.9M 555.8M 479.7M
Gross Profit i 336.2M 302.1M 280.5M 243.2M 223.9M
Gross Margin % i 35.3% 32.7% 29.8% 30.4% 31.8%
Operating Expenses
Research & Development i 16.8M 15.0M 12.2M 13.5M 10.3M
Selling, General & Administrative i 136.5M 127.8M 123.1M 102.1M 102.4M
Other Operating Expenses i - - - - -
Total Operating Expenses i 153.3M 142.9M 135.3M 115.7M 112.8M
Operating Income i 182.9M 159.2M 145.2M 127.5M 111.1M
Operating Margin % i 19.2% 17.3% 15.4% 16.0% 15.8%
Non-Operating Items
Interest Income i - - - - -
Interest Expense i 16.5M 22.6M 10.3M 2.5M 4.4M
Other Non-Operating Income 72.0K 681.0K -1.2M 187.0K -291.0K
Pre-tax Income i 166.5M 137.3M 133.7M 125.2M 106.4M
Income Tax i 38.0M 28.7M 28.4M 29.1M 21.8M
Effective Tax Rate % i 22.8% 20.9% 21.2% 23.3% 20.5%
Net Income i 128.5M 108.5M 105.4M 96.1M 84.6M
Net Margin % i 13.5% 11.8% 11.2% 12.0% 12.0%
Key Metrics
EBITDA i 231.0M 214.8M 195.9M 176.6M 162.1M
EPS (Basic) i $3.95 $3.37 $3.28 $2.98 $2.61
EPS (Diluted) i $3.93 $3.35 $3.25 $2.94 $2.60
Basic Shares Outstanding i 32527244 32254728 32152787 32287150 32372621
Diluted Shares Outstanding i 32527244 32254728 32152787 32287150 32372621

Income Statement Trend

Balchem Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets
Cash & Equivalents i 49.5M 64.4M 66.6M 103.2M 84.6M
Short-term Investments i - - - - -
Accounts Receivable i 119.7M 125.3M 131.6M 117.4M 98.2M
Inventory i 130.8M 109.5M 119.7M 91.1M 70.6M
Other Current Assets 5.7M 7.2M 7.1M 4.4M 3.4M
Total Current Assets i 313.8M 314.2M 335.8M 322.2M 266.9M
Non-Current Assets
Property, Plant & Equipment i 332.1M 332.6M 298.3M 9.3M 8.4M
Goodwill i 1.7B 1.7B 1.8B 1.1B 1.2B
Intangible Assets i 165.0M 191.2M 213.3M 94.7M 121.7M
Long-term Investments - - - - -
Other Non-Current Assets 17.3M 16.9M 15.1M 11.7M 11.3M
Total Non-Current Assets i 1.3B 1.3B 1.3B 877.1M 899.0M
Total Assets i 1.6B 1.6B 1.6B 1.2B 1.2B
Liabilities
Current Liabilities
Accounts Payable i 54.7M 55.5M 57.3M 56.2M 23.7M
Short-term Debt i 3.3M 4.2M 4.0M 2.4M 2.3M
Current Portion of Long-term Debt - - - - -
Other Current Liabilities - - - - -
Total Current Liabilities i 157.7M 148.5M 140.0M 143.8M 94.4M
Non-Current Liabilities
Long-term Debt i 204.7M 326.1M 456.6M 115.7M 169.6M
Deferred Tax Liabilities i 43.7M 52.0M 62.8M 46.5M 51.4M
Other Non-Current Liabilities 19.3M 16.6M 26.8M 13.7M 10.5M
Total Non-Current Liabilities i 267.8M 394.7M 546.2M 178.5M 243.2M
Total Liabilities i 425.5M 543.2M 686.2M 322.3M 337.6M
Equity
Common Stock i 2.2M 2.2M 2.1M 2.2M 2.2M
Retained Earnings i 997.5M 897.5M 814.5M 732.1M 656.7M
Treasury Stock i - - - - 7.9M
Other Equity - - - - -
Total Shareholders Equity i 1.1B 1.1B 938.3M 877.0M 828.2M
Key Metrics
Total Debt i 208.0M 330.3M 460.6M 118.0M 172.0M
Working Capital i 156.1M 165.8M 195.8M 178.4M 172.5M

Balance Sheet Composition

Balchem Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income i 128.5M 108.5M 105.4M 96.1M 84.6M
Depreciation & Amortization i 48.0M 54.9M 51.8M 48.9M 51.3M
Stock-Based Compensation i 16.7M 16.1M 13.2M 10.8M 8.3M
Working Capital Changes i -15.4M 20.0M -11.5M -35.3M 12.4M
Operating Cash Flow i 170.8M 177.4M 150.5M 114.6M 152.0M
Investing Activities
Capital Expenditures i - - - - -
Acquisitions i -24.4M -1.5M -366.3M -86.0K 0
Investment Purchases i - - - - -
Investment Sales i 0 2.7M 0 0 -
Investing Cash Flow i -24.1M 3.1M -366.1M 2.1M -763.0K
Financing Activities
Share Repurchases i -5.7M -4.5M -35.4M -35.2M -13.5M
Dividends Paid i -25.6M -22.9M -20.7M -18.7M -16.7M
Debt Issuance i 26.0M 18.0M 435.0M 5.0M 10.0M
Debt Repayment i -145.8M -149.2M -134.2M -60.2M -95.2M
Financing Cash Flow i -151.0M -158.6M 243.5M -109.1M -200.3M
Free Cash Flow i 146.3M 145.9M 88.6M 123.2M 116.7M
Net Change in Cash i -4.3M 21.9M 27.9M 7.5M -49.1M

Cash Flow Trend

Balchem Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 32.38
Forward P/E 28.93
Price to Book 3.61
Price to Sales 4.65
PEG Ratio 1.68

Profitability Ratios

Profit Margin 14.48%
Operating Margin 20.30%
Return on Equity 11.99%
Return on Assets 7.66%

Financial Health

Current Ratio 2.64
Debt to Equity 16.38
Beta 0.92

Per Share Data

EPS (TTM) $4.36
Book Value per Share $39.07
Revenue per Share $30.44

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
bcpc 4.7B 32.38 3.61 11.99% 14.48% 16.38
Linde plc 222.6B 34.37 5.86 17.01% 20.02% 60.56
Sherwin-Williams 84.2B 33.46 19.05 62.43% 11.03% 308.57
Albemarle 9.9B 33.52 1.26 -9.99% -22.39% 35.76
NewMarket 8.2B 16.98 5.00 33.74% 17.28% 56.98
Eastman Chemical 7.3B 8.77 1.23 14.39% 8.96% 90.60

Financial data is updated regularly. All figures are in the company's reporting currency.